N/A
N=781
Examining How a Text Message-based Educational Intervention Influences COVID-19 Testing
COVID-19 Testing Behaviors
Bottom Line
View on ClinicalTrials.gov: NCT07074171 ↗Enrolled (actual)
781
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcome: Primary: Number of Participants Who Self-Reported Use of a COVID-19 Antigen or PCR Test — 31; 22 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Text message-based education intervention (Behavioral); Historical Control (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- The University of Texas Health Science Center, Houston
- Primary completion
- Dec 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Self-Reported Use of a COVID-19 Antigen or PCR Test |
60; 46 | — |
| PRIMARY Number of Participants Who Self-Reported Use of a COVID-19 Antigen or PCR Test |
60; 46 | — |
| SECONDARY Number of Participants Who Self-reported Receiving COVID-19 Vaccination |
259; 12 | — |
| SECONDARY Number of Participants Who Self-reported Receiving COVID-19 Vaccination |
259; 12 | — |
| SECONDARY Number of Participants Who Self-reported Used Mitigation Measures if a Positive Test is Obtained |
— | — |
Summary
In this Phase III study, the investigators will build off of the Phase II embedded study with some adjustments to the design to address new research priorities that examine an intervention that is network informed and delivered through community health worker interactions plus digitally-delivered intervention content with the goal of increasing COVID-19 testing and vaccination. This model, if proven effective, can be scaled up to address COVID-19 and other future pandemics. The investigators will utilize the sample of intervention priority census block groups (PBGs) used in Phase II and will recruit and enroll participants not previously enrolled in either phase I or II from these PBGs using convenience sampling methods. The investigators will use a historical control group consisting of participants from our control arm in Phase II who completed both their baseline and follow-up surveys embedded in the study.
Eligibility Criteria
Inclusion Criteria
- having a smartphone that accepts text messages
Exclusion Criteria
- having been diagnosed with COVID-19 in the past 30 days based on a positive test (antigen or PCR) or a clinical diagnosis
- having tested for COVID-19 with PCR or antigen test within the past 30 days
- not being available in the recruitment area in the next 60 days
- having been an embedded study participant
- having been a snowball study participant.
Data sourced from ClinicalTrials.gov (NCT07074171). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.